New, Improved Approach To Mammograms
News Sep 18, 2015
In their report they describe injecting gold nanoparticles in mammary tissue to enhance the imaging of early signs of breast cancer.
Mammography remains the clinical gold standard of screening tests for detecting breast cancer. However, a recognized limitation of this X-ray procedure is that dense breast tissue shows up as white masses and fibers on an image, which can obscure the presence of microcalcifications — potential signs of early cancer development. Other imaging methods including ultrasound, magnetic resonance imaging and molecular breast imaging can also find abnormalities, but each has its own limitation, such as high cost or poor resolution. Lisa Cole, Tracy Vargo-Gogola and Ryan K. Roeder wanted to improve patients’ options.
The researchers boosted the contrast of mammography X-rays by modifying gold nanoparticles with molecules that bind specifically to microcalcifications. They injected a low dose of these nanoparticles into the mammary glands of mice with dense tissue. The engineered particles made the microcalcifications brighter on the X-rays — and therefore, easier to distinguish. The mice showed no obvious side effects. Although further research would be required, the scientists say the technique could eventually translate into more reliable breast cancer detection for women with dense mammary tissue.
"Cell Quake Elastography" Maps Elasticity of Cell ComponentsNews
In somewhat the same way that seismologists use the vibrations of planet Earth to characterize its deep structure, scientists have discovered a way to use vibrations within cells to identify their mechanical properties.READ MORE
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE
New Biomarkers Predict Outcome of Cancer ImmunotherapyNews
Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage.READ MORE
Comments | 0 ADD COMMENT
Precision Medicine & Biomarkers Leaders Summit: USA
May 07 - May 08, 2018